Thiopental, powder/lyophilisate, 1 g, Propofol Fresenius, emulsion, 10 mg/ml, 20 ml

This tender concerns the procurement of essential anesthetic medications, specifically Thiopental powder/lyophilisate (1 g) and Propofol Fresenius emulsion (10 mg/ml, 20 ml). Both items fall under the classification of medicines for the treatment of nervous system diseases and sensory organ diseases, with a common CPV code of 33660000-4. The procuring entity is the Communal Non-Profit Enterprise "Valkivska Central District Hospital".

The procurement aims to ensure the availability of critical drugs necessary for surgical procedures and intensive care within the hospital's services. Thiopental is a barbiturate commonly used for the induction of general anesthesia and short-term sedation, while Propofol is a widely used intravenous hypnotic agent for the induction and maintenance of anesthesia, as well as for sedation in intensive care units. The specific quantities and packaging detailed in the tender documents will be crucial for bidders to meet the hospital's needs accurately. This acquisition is vital for maintaining the operational capacity of the surgical and anesthesiology departments of the Valkivska Central District Hospital, ensuring patient safety and effective medical treatment. Potential suppliers are expected to provide high-quality pharmaceutical products that comply with all relevant national and international standards for medicinal products.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals, Medical Equipment and Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 60,600.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.